Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-29

FDA Approved: NIFEDIPINE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved the original application for Nifedipine from Zydus Lifesciences Limited, a generic calcium channel blocker used for hypertension and angina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine (nifedipine)

Snippet

ORIG AP for NIFEDIPINE (NIFEDIPINE)